AbbVie Inc. (ABBV) Social Stream
ABBVIE INC (ABBV) Price Targets From Analysts
Use the tables below to see what analysts covering ABBVIE INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 13 | $140 | $118 | $128 | $140.34 | -8.79% |
| 2021-11-23 | 12 | $172 | $118 | $133.083 | $140.34 | -5.17% |
| 2022-01-03 | 13 | $172 | $118 | $135.538 | $140.34 | -3.42% |
| 2022-01-05 | 13 | $172 | $118 | $140.923 | $140.34 | 0.42% |
| 2022-01-14 | 13 | $172 | $118 | $143.416 | $140.34 | 2.19% |
| 2022-01-19 | 13 | $172 | $118 | $147.166 | $140.34 | 4.86% |
| 2022-02-01 | 13 | $172 | $133 | $149.916 | $140.34 | 6.82% |
| 2022-02-03 | 13 | $180 | $133 | $151.416 | $140.34 | 7.89% |
| 2022-02-14 | 13 | $180 | $133 | $153.5 | $140.34 | 9.38% |
| 2022-02-17 | 13 | $180 | $133 | $154.083 | $140.34 | 9.79% |
| 2022-03-08 | 14 | $180 | $133 | $153.538 | $140.34 | 9.4% |
| 2022-03-16 | 14 | $180 | $133 | $154.076 | $140.34 | 9.79% |
| 2022-04-06 | 13 | $192 | $133 | $159.833 | $140.34 | 13.89% |
| 2022-04-13 | 12 | $192 | $147 | $163.25 | $140.34 | 16.32% |
| 2022-04-18 | 13 | $192 | $147 | $163.25 | $140.34 | 16.32% |
| 2022-04-22 | 13 | $192 | $147 | $166.083 | $140.34 | 18.34% |
| 2022-04-29 | 13 | $192 | $147 | $167.833 | $140.34 | 19.59% |
| 2022-05-02 | 13 | $200 | $147 | $170.75 | $140.34 | 21.67% |
| 2022-05-11 | 13 | $200 | $147 | $168.846 | $140.34 | 20.31% |
| 2022-05-20 | 14 | $200 | $140 | $166.785 | $140.34 | 18.84% |
| 2022-06-09 | 15 | $200 | $140 | $165 | $140.34 | 17.57% |
| 2022-07-22 | 15 | $200 | $140 | $165.2 | $140.34 | 17.71% |
| 2022-07-29 | 14 | $200 | $140 | $165.2 | $140.34 | 17.71% |
| 2022-08-01 | 16 | $200 | $140 | $165 | $140.34 | 17.57% |
| 2022-08-14 | 15 | $200 | $140 | $163.562 | $140.34 | 16.55% |
The Trend in the Analyst Price Target
Over the past 27 months, ABBV's average price target has gone up $64.85.
Over the past 41 weeks, ABBV's average upside potential has been 9.05%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-08 | 14 | 180 | 133 | 153.538 | 147.15 | 4.34% |
| 2022-04-18 | 13 | 192 | 147 | 163.250 | 159.36 | 2.44% |
| 2022-05-06 | 13 | 200 | 147 | 168.846 | 152.83 | 10.48% |
| 2022-05-11 | 13 | 200 | 147 | 168.846 | 151.96 | 11.11% |
| 2022-06-09 | 15 | 200 | 140 | 165.000 | 145.43 | 13.46% |
ABBV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.1 | 7 | 1 | 6 | 1 | 1 | 15 |
The Trend in the Broker Recommendations
ABBV's average broker recommendation rating worsened by 0.57 over the prior 24 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ABBV has a greater average analyst price target than 3290.99% of Pharmaceutical Products stocks.
- ABBVIE INC's upside potential (average analyst target price relative to current price) is higher than 340.51% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ABBVIE INC's number of analysts covering the stock is higher than 3206.82% of them.
- In the context of Pharmaceutical Products stocks, ABBVIE INC's variance in analysts' estimates is lower than -698.91% of them.
In the Pharmaceutical Products industry, TECH, SGEN, and RGEN are the three stocks most similar to ABBVIE INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is ABBV a Buy, Hold or Sell? See the POWR Ratings now!